Reactome | adalimumab [extracellular region]

Schema > ProteinDrug > Entries

authored	[InstanceEdit:9709348] Stephan, Ralf, 2020-12-14
compartment	[Compartment:984] extracellular region
created	[InstanceEdit:9715007] Stephan, Ralf, 2021-02-16
crossReference	[DatabaseIdentifier:12021176] Mondo:0020283
dbId	9714991
disease	[Disease:9660768] Crohn's disease [Disease:9660849] ankylosing spondylitis [Disease:9714534] hidradenitis suppurativa [Disease:9660843] psoriatic arthritis [Disease:5663017] rheumatoid arthritis [Disease:9625953] ulcerative colitis [Disease:9714290] uveitis [Disease:9660847] juvenile rheumatoid arthritis [Disease:9009814] psoriasis
displayName	adalimumab [extracellular region]
inDisease	true
literatureReference	[LiteratureReference:9714967] Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7
maxDepth	1
memberOf	[DefinedSet:R-ALL-9714904] TNF-alpha inhibitors [extracellular region]
name	adalimumab
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:4860] adalimumab [Guide to Pharmacology:4860]
schemaClass	ProteinDrug
stId	R-ALL-9714991

(hasMember)

Cite Us!